World's Best Scientists 2026 revealed!
Charles J. Parker

Charles J. Parker

D-Index & Metrics

Biology and Biochemistry

D-Index
53
Citations
10020
World Ranking
16174
National Ranking
6701

Charles J. Parker publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Charles J. Parker sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 176 publications — 39th percentile

39% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Charles J. Parker D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Charles J. Parker sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 53 D-Index — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Research.com Recognitions

  • 1959 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Charles J. Parker is affiliated with the University of Utah in the United States. Their research spans multiple fields, primarily focusing on Medicine and Biochemistry, Genetics and Molecular Biology. Their work engages extensively with subfields such as Molecular Biology, Pulmonary and Respiratory Medicine, Pediatrics, Perinatology and Child Health, Immunology, and Hematology.

The scientist's main topics of study include Porphyrin Metabolism and Disorders, Heme Oxygenase-1 and Carbon Monoxide, Prostate Cancer Treatment and Research, Neonatal Health and Biochemistry, Prostate Cancer Diagnosis and Treatment, Radiomics and Machine Learning in Medical Imaging, and the Complement System in Diseases.

Frequent collaborators in their research include Gerhardt Attard, Manisha Balwani, Herbert L. Bonkovsky, D. Montgomery Bissell, and Karl E. Anderson.

The publication venues where Charles J. Parker has published most often include:

  • New England Journal of Medicine
  • British Journal of Haematology
  • The American Journal of Gastroenterology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Lancet

Representative recent papers authored or coauthored by Parker emphasize clinical studies and trials in hepatology, oncology, and molecular therapeutics:

  • "Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria," 2020, New England Journal of Medicine
  • "The Lancet Commission on prostate cancer: planning for the surge in cases," 2024, The Lancet
  • "Efficacy and safety of givosiran for acute hepatic porphyria: 24-month interim analysis of the randomized phase 3 ENVISION study," 2021, Liver International
  • "Dersimelagon in Erythropoietic Protoporphyrias," 2023, New England Journal of Medicine
  • "1767MO External validation of a digital pathology-based multimodal artificial intelligence (MMAI)-derived model in high-risk localized (M0)/metastatic (M1) prostate cancer (PCa) starting androgen deprivation therapy (ADT) in the docetaxel (Doc) or abiraterone (AAP) phase III STAMPEDE trials," 2023, Annals of Oncology

Charles J. Parker was recognized as a Fellow of the American Association for the Advancement of Science (AAAS) in 1959.

Best Publications

  • Diagnosis and management of paroxysmal nocturnal hemoglobinuria.

    Charles Parker;Mitsuhiro Omine;Stephen Richards;Jun-Ichi Nishimura

  • Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria.

    M H Holguin;L R Fredrick;N J Bernshaw;L A Wilcox

  • Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria

    Manisha Balwani;Eliane Sardh;Paolo Ventura;Paula Aguilera Peiró

  • Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.

    G D Ross;W J Yount;M J Walport;J B Winfield

  • Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction.

    Mohammed Saifuddin;Tarlan Hedayati;John P. Atkinson;Mark H. Holguin

  • Afamelanotide for Erythropoietic Protoporphyria

    J. G. Langendonk;M. Balwani;Karl Anderson;H. L. Bonkovsky

  • Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV).

    Gregory T. Spear;Nell S. Lurain;Charles J. Parker;Mahmood Ghassemi

  • Phase 1 Trial of an RNA Interference Therapy for Acute Intermittent Porphyria

    Eliane Sardh;Pauline Harper;Manisha Balwani;Penelope Stein

  • Eculizumab for paroxysmal nocturnal haemoglobinuria.

    Charles Parker

  • Activation of complement by hemodialysis membranes: polyacrylonitrile binds more C3a than cuprophan.

    Alfred K. Cheung;Charles J. Parker;Linda A. Wilcox;Jarmila Janatova

  • Relationship between the membrane inhibitor of reactive lysis and the erythrocyte phenotypes of paroxysmal nocturnal hemoglobinuria.

    M H Holguin;L A Wilcox;N J Bernshaw;W F Rosse

  • The regulation of platelet-activating factor production in endothelial cells. The role of calcium and protein kinase C.

    R. E. Whatley;P. Nelson;G. A. Zimmerman;D. L. Stevens

  • Molecular basis of clonal expansion of hematopoiesis in 2 patients with paroxysmal nocturnal hemoglobinuria (PNH).

    Norimitsu Inoue;Tomohisa Izui-Sarumaru;Yoshiko Murakami;Yuichi Endo

  • Molecular basis of the enhanced susceptibility of the erythrocytes of paroxysmal nocturnal hemoglobinuria to hemolysis in acidified serum.

    Linda A. Wilcox;John L. Ezzell;Nicole J. Bernshaw;Charles J. Parker

  • Paroxysmal nocturnal haemoglobinuria.

    Wendell F. Rosse;Charles J. Parker

  • Detection of the membrane inhibitor of reactive lysis (CD59) in diseased neurons of Alzheimer brain.

    P.L. McGeer;D.G. Walker;H. Akiyama;T. Kawamata

  • Vitronectin is a substrate for transglutaminases.

    David C. Sane;Tammy L. Moser;Anne M.M. Pippen;Charles J. Parker

  • EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks

    Laurent Gouya;Paolo Ventura;Manisha Balwani;D. Montgomery Bissell

  • Liver transplantation in the management of porphyria

    Ashwani K. Singal;Charles Parker;Christine Bowden;Manish Thapar

  • The pathophysiology of paroxysmal nocturnal hemoglobinuria

    Charles J. Parker

Frequent Co-Authors

John D. Phillips
John D. Phillips University of Utah
Lawrie W. Powell
Lawrie W. Powell University of Queensland
Alfred K. Cheung
Alfred K. Cheung University of Utah
Robert J. Desnick
Robert J. Desnick Icahn School of Medicine at Mount Sinai
Gregory J. Anderson
Gregory J. Anderson QIMR Berghofer Medical Research Institute
Carl T. Wittwer
Carl T. Wittwer University of Utah
Katrina J. Allen
Katrina J. Allen University of Melbourne
John F. Bohnsack
John F. Bohnsack University of Utah
Taroh Kinoshita
Taroh Kinoshita Osaka University
Jaroslav Jelinek
Jaroslav Jelinek Coriell Institute For Medical Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry in the USA can open doors to numerous dynamic career options. Advancements in online education have made it more convenient than ever to pursue specialized degrees from anywhere. For example, if you are interested in healthcare and pharmaceuticals, pursuing the best online pharmacy school can empower you with advanced pharmaceutical knowledge and career mobility.

Many students seek alternative paths in allied health, sports science, or rehabilitation. If you prefer fields related to human movement, an online bachelor's degree in exercise science or a kinesiology degree online could be ideal, offering flexible learning and strong job prospects in fitness, wellness, and research settings.

For those interested in mental health, options such as a 1 year pmhnp program (Psychiatric Mental Health Nurse Practitioner) provide expedited routes to advanced patient care roles.

Whether you're aiming for pharmacy, exercise science, kinesiology, or mental health, online programs offer accessible and reputable ways to gain the skills and credentials needed for a rewarding scientific career.

Best Scientists Citing Charles J. Parker

Trending Scientists

Recently Published Articles